The Vanguard Group 13D and 13G filings for Treace Medical Concepts, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 6:01 pm Unchanged |
2024-09-30 | 13G | Treace Medical Concepts, Inc. TMCI |
The Vanguard Group | 2,741,488 4.400% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:58 pm Sale |
2024-09-30 | 13G | Treace Medical Concepts, Inc. TMCI |
The Vanguard Group | 2,741,488 4.400% |
-1,552,301 (-36.15%) |
Filing |
| 2024-02-13 5:15 pm Purchase |
2023-12-29 | 13G | Treace Medical Concepts, Inc. TMCI |
The Vanguard Group | 4,293,789 6.960% |
1,016,940 (+31.03%) |
Filing |
| 2023-02-09 11:35 am Purchase |
2022-12-30 | 13G | Treace Medical Concepts, Inc. TMCI |
The Vanguard Group | 3,276,849 5.900% |
3,276,849 (New Position) |
Filing |